Latest News and Press Releases
Want to stay updated on the latest news?
-
Med hänvisning till 4 kap. 9 § lagen (1991:980) om handel med finansiella instrument meddelas härmed att utnyttjande av teckningsoptioner i Aerocrine inneburit att antalet aktier och röster i bolaget...
-
Solna (Sweden) – Aerocrine AB (OMX Nordic Exchange: AERO) today announced that NICE (National Institute for Health and Care Excellence) has notified stakeholders that the final guidelines recommending...
-
Solna, 21 mars, 2014 – Aerocrine AB (OMX Nordic Exchange: AERO) meddelar idag att NICE (National Institute for Health and Care Excellence) kommer informera sina intressenter om att de i april...
-
SOLNA, Sverige, 19 mars, 2014 – Aerocrine AB (OMX Nordic Exchange: AERO) meddelar att amerikanska sjukförsäkringsbolaget Health Care Service Corporation (HCSC) börjar kostnadsersätta FeNO-tester för...
-
SOLNA, Sweden - 19 March, 2014 - Aerocrine AB (OMX Nordic Exchange: AERO) announces that Health Care Service Corporation will begin covering FeNO testing for asthma diagnosis and management effective...
-
Global sales demonstrate mixed results. US grows year over year and commercial approach being adjusted and refocused to optimize results. January – December 2013 · Global Net sales decreased by 7%...
-
Globala nettoomsättningen visar skiftande resultat medan USA växer under 2013. Kommersiella strategin i USA justeras för framtida resultatoptimering. Januari – december 2013 · Nettoomsättningen...
-
Solna – 17 januari 2014 – Aerocrine AB (OMX Nordic Exchange: AERO) meddelar idag att man har slutit ett exklusivt distributionsavtal med Healthcare 21, ett brittisk-irländskt bolag som arbetar med...
-
Solna (Sweden) – January 17, 2014 – Aerocrine AB (OMX Nordic Exchange: AERO) today announces the signing of an exclusive agreement with UK & Irish medical device company Healthcare 21 Ltd for sales,...
-
With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the subscription by a new share issue in Aerocrine the number of...